Redx Pharma Plc (REDX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,092 | 53,854 | 29,552 | 27,513 | 3,704 |
| Other current assets | 5,210 | 5,524 | 6,263 | 839 | 1,426 |
| TOTAL | $23,302 | $59,378 | $35,815 | $29,468 | $5,807 |
| Non-Current Assets | |||||
| PPE Net | 1,940 | 2,699 | 3,325 | 3,709 | 134 |
| Intangibles | 394 | 400 | 405 | 411 | 417 |
| TOTAL | $2,334 | $3,099 | $3,730 | $4,120 | $551 |
| Total Assets | $25,636 | $62,477 | $39,545 | $33,588 | $6,358 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 15,731 | 15,731 | N/A | N/A | 468 |
| Accounts payable and accrued liabilities | 913 | 2,792 | 1,789 | 1,845 | 1,490 |
| TOTAL | $21,007 | $27,205 | $9,592 | $10,934 | $4,867 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | 14,247 | 16,758 | N/A |
| TOTAL | $1,274 | $1,951 | $16,821 | $19,967 | $0 |
| Total Liabilities | $22,281 | $29,156 | $26,413 | $30,901 | $4,867 |
| Shareholders' Equity | |||||
| Common Shares | 3,349 | 3,349 | 2,753 | 1,952 | 1,265 |
| Retained earnings | -113,827 | -81,313 | -64,226 | -42,213 | -34,142 |
| Other shareholders' equity | 14,331 | 11,783 | 8,305 | 5,763 | 1,104 |
| TOTAL | $3,355 | $33,321 | $13,132 | $2,687 | $1,491 |
| Total Liabilities And Equity | $25,636 | $62,477 | $39,545 | $33,588 | $6,358 |